Abstract
The article provides an overview of domestic and foreign literature on the relevance of developing and implementing comprehensive medical and social methods for the prevention and treatment of gerontological pathologies. It examines the morphological and biochemical foundations of brain aging and presents methods for pharmacological correction of these changes. The use of the original domestic drug, the breadth of therapeutic effects of the drug ethylmethylhydroxypyridine succinate (Meksidol), based on its biochemical mechanisms of action, its high clinical efficacy, and the favorable safety profile of Meksidol in the absence of drug interactions, make its use promising in the comprehensive treatment of older patients.
Affiliated Institutions
Related Publications
World guidelines for falls prevention and management for older adults: a global initiative
Abstract Background falls and fall-related injuries are common in older adults, have negative effects on functional independence and quality of life and are associated with incr...
Treatment to Prevent Transmission of HIV‐1
Antiretroviral therapy (ART) has the potential to prevent human immunodeficiency virus (HIV) transmission by reducing the concentration of HIV in blood and genital secretions. I...
Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view
Abstract The last two decades have seen an explosive increase in the number of people with diabetes globally. There is now an urgent need for strategies to prevent the emerging ...
The Scherrer Formula for X-Ray Particle Size Determination
An exact derivation of the Scherrer equation is given for particles of spherical shape, values of the constant for half-value breadth and for integral breadth being obtained. Va...
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
The International Diabetes Federation estimates that 415 million adults worldwide now have diabetes and 318 million have impaired glucose tolerance. These numbers are expected t...
Publication Info
- Year
- 2025
- Type
- article
- Volume
- 125
- Issue
- 11
- Pages
- 132-132
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
0
OpenAlex
Cite This
E I Chukanova
(2025).
Brain aging: molecular targets of geroprotection and prevention strategies.
S S Korsakov Journal of Neurology and Psychiatry
, 125
(11)
, 132-132.
https://doi.org/10.17116/jnevro2025125111132
Identifiers
- DOI
- 10.17116/jnevro2025125111132